BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30063081)

  • 1. Microwave vs radiofrequency ablation for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Liu W; Zheng Y; He W; Zou R; Qiu J; Shen J; Yang Z; Zhang Y; Wang C; Wang Y; Zuo D; Li B; Yuan Y
    Aliment Pharmacol Ther; 2018 Sep; 48(6):671-681. PubMed ID: 30063081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Microwave and Radiofrequency Ablation for the Treatment of Small- and Medium-Sized Hepatocellular Carcinomas in a Prospective Randomized Trial.
    Vogl TJ; Martin SS; Gruber-Rouh T; Booz C; Koch V; Nour-Eldin NA; Hussainy Said MN
    Rofo; 2024 May; 196(5):482-490. PubMed ID: 38065541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microwave ablation is as effective as radiofrequency ablation for very-early-stage hepatocellular carcinoma.
    Xu Y; Shen Q; Wang N; Wu PP; Huang B; Kuang M; Qian GJ
    Chin J Cancer; 2017 Jan; 36(1):14. PubMed ID: 28103953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave ablation versus laparoscopic resection for hepatocellular carcinoma in patients with clinically significant portal hypertension: a propensity score-matched study of postoperative liver decompensation.
    Yu H; Zhao F; Men X; Zhu H; Yan J; Liu Z; Liu Q; Feng Y; Wang L; Meng M; Zhu Q; Zhao X
    Eur Radiol; 2024 May; 34(5):3226-3235. PubMed ID: 37875593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAGES/AHPBA guidelines for the use of microwave and radiofrequency liver ablation for the surgical treatment of hepatocellular carcinoma or colorectal liver metastases less than 5 cm.
    Ceppa EP; Collings AT; Abdalla M; Onkendi E; Nelson DW; Ozair A; Miraflor E; Rahman F; Whiteside J; Shah MM; Ayloo S; Dirks R; Kumar SS; Ansari MT; Sucandy I; Ali K; Douglas S; Polanco PM; Vreeland TJ; Buell J; Abou-Setta AM; Awad Z; Kwon CH; Martinie JB; Sbrana F; Pryor A; Slater BJ; Richardson W; Jeyarajah R; Alseidi A
    Surg Endosc; 2023 Dec; 37(12):8991-9000. PubMed ID: 37957297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation versus microwave ablation for hepatocellular carcinoma with cirrhosis: a propensity score analysis.
    Xiong Y; Zhang Y; Hu C
    Transl Cancer Res; 2024 Apr; 13(4):1807-1820. PubMed ID: 38737685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival analysis of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma conforming to the Milan criteria: primary versus recurrent HCC.
    Zhang J; Guo G; Li T; Guo C; Han Y; Zhou X
    Int J Hyperthermia; 2024; 41(1):2318829. PubMed ID: 38467417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complication Rates and Risk of Recurrence After Percutaneous Radiofrequency Ablation and Microwave Ablation for the Treatment of Liver Tumors: a Meta-analysis.
    Alhasan AS; Daqqaq TS; Alhasan MS; Ghunaim HA; Aboualkheir M
    Acad Radiol; 2024 Apr; 31(4):1288-1301. PubMed ID: 38087720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma.
    Alitti C; Rode A; Trillaud H; Merle P; Blanc JF; Blaise L; Demory A; Nkontchou G; Grando V; Ziol M; Nahon P; Ganne-Carrié N; Petit A; Seror O; Sutter O; Nault JC
    Liver Int; 2024 Jun; 44(6):1363-1372. PubMed ID: 38436538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal application of stereotactic body radiotherapy and radiofrequency ablation treatment for different multifocal hepatocellular carcinoma lesions in patients with Barcelona Clinic Liver Cancer stage A4-B1: a pilot study.
    Wang F; Numata K; Takeda A; Ogushi K; Fukuda H; Nihonmatsu H; Hara K; Chuma M; Tsurugai Y; Maeda S
    BMC Cancer; 2021 Oct; 21(1):1169. PubMed ID: 34717577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies.
    Chen W; Lin X; Wu Z; Pan W; Ke Q; Chen Y
    Hepatol Int; 2024 Jun; 18(3):998-1010. PubMed ID: 38480604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pan-immune-inflammation value in hepatocellular carcinoma treated by curative radiofrequency ablation: potential role for individualized adjuvant systemic treatment.
    Liang X; Bu J; Jiang Y; Zhu S; Ye Q; Deng Y; Lu W; Liu Q
    Int J Hyperthermia; 2024; 41(1):2355279. PubMed ID: 38767372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cell-cytokine killer combined with microwave ablation reduced recurrence for hepatocellular carcinoma compared to ablation alone.
    Wang L; Li X; Dong XJ; Yu XL; Zhang J; Cheng ZG; Han ZY; Liu FY; Yu J; Liang P
    Technol Health Care; 2024; 32(3):1819-1834. PubMed ID: 38393935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic liver resection versus radiofrequency ablation for caudate lobe solitary hepatocellular carcinoma: A propensity score matching study.
    Wang Z; Ouyang J; Jia B; Zhou Y; Yang Y; Li X; Li Q; Zhou J
    Cancer Med; 2024 Feb; 13(4):e7068. PubMed ID: 38457235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of microwave ablation with parallel acupuncture guided by ultrasound in treating single hepatocellular carcinoma in high-risk areas: A retrospective analysis of 155 patients.
    Liu S; Zhou P; Shen Q; Qian G
    J Cancer Res Ther; 2024 Apr; 20(2):547-554. PubMed ID: 38687924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microwave ablation is superior to radiofrequency ablation in the treatment of hepatocellular carcinoma below 5 cm - A systematic review and meta-analysis.
    Zhang L; Du F; Zhang Y; Yangdan C; Wang H; Ren L
    J Minim Access Surg; 2023; 19(4):453-458. PubMed ID: 37706417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma ≤ 5 cm without cirrhosis: A population-based study with stratification by tumor size.
    Dong SC; Bai DS; Wang FA; Jin SJ; Zhang C; Zhou BH; Jiang GQ
    Hepatobiliary Pancreat Dis Int; 2023 Dec; 22(6):605-614. PubMed ID: 35977873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography-guided percutaneous cryoablation and microwave ablation in the treatment of perivascular hepatocellular carcinoma: A comparative study with propensity score matching.
    Li B; Ren ZW; Zhang C; Yu XX; Xu XX; Du Y; Yang HF
    Clin Res Hepatol Gastroenterol; 2024 Mar; 48(3):102298. PubMed ID: 38367802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy.
    Tada F; Hiraoka A; Nakatani K; Matsuoka K; Fukumoto M; Matsuda T; Yanagihara E; Saneto H; Murakami T; Onishi K; Izumoto H; Kitahata S; Kanemitsu-Okada K; Kawamura T; Kuroda T; Hanaoka J; Watanabe J; Ohtani H; Yoshida O; Hirooka M; Miyata H; Tsubouchi E; Abe M; Matsuura B; Ninomiya T; Hiasa Y
    Clin J Gastroenterol; 2024 Jun; 17(3):401-411. PubMed ID: 38528198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular Carcinoma.
    Kim JI; Lee J; Choi GH; Lee MW; Park DA; Yoo JJ
    Dig Dis Sci; 2024 Mar; 69(3):1055-1067. PubMed ID: 38300416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.